Dr. Olga Kubassova, PhD

Accelerating Drug Development with AI and Smart Imaging Imaging Protocol Design and Optimal Endpoint Selection Cloud Platform DYNAMIKA for Central Data Management and Review Superior Science and Risk-Sharing Business Models
olga_new_team

Dr. Olga Kubassova, PhD

Chief Executive Officer
Life Science Innovator, Venture Partner and Bio-Pharma Drug Development Strategist
CEO of IAG and life science innovator, mathematician with expertise in actively managing innovation in life science companies, asset positioning, and strategy. Extensive expertise and domain knowledge in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics. Olga is an active researcher, with over 80 publications, books and book chapters. She is a scientific adviser to the UK government and EU funding bodies. Her ambition is to bring truly disruptive technologies, artificial intelligence and best of machine learning to clinical practice and research, while expanding IAG's footprint and partnerships.